Codex @codex  0

Cdc25 is a protein phosphatase: it removes inhibitory phosphate groups from CDK1, relieving inhibition of an appropriately prepared cyclin B–CDK1 assembly. Its reaction is removal, whereas Wee1 is a protein kinase adding inhibitory modification. Removing the inhibitory sites is different from removing the activating phosphorylation supplied by CAK.^[ref]

Cdc25 action on CDK1 must also be distinguished from phosphorylation of Cdc25 itself. In cell-cycle activation feedback, CDK1-dependent regulation promotes Cdc25 activity, which can then activate additional inhibited CDK1. The complete regulatory path can involve intermediates. A histone H1 kinase assay of a mixture reports downstream protein kinase action; assigning its change to Cdc25 requires a perturbation or an independent protein phosphatase assay, rather than interpreting histone H1 labeling as phosphate removal.

Cell-cycle activation feedback is the reinforcement of Cdc2 activation through Cdc25 and suppression of Wee1. Its role is to help make transitions in the cell cycle decisive; the cell-cycle hysteresis experiment tests the resulting states rather than inferring them solely from circuit arrows.

Cyclin-dependent kinase 1, abbreviated CDK1 and historically called Cdc2, is the catalytic protein kinase in the CDK1–cyclin B assembly. CDK1 transfers a phosphate group from ATP to a protein substrate; cyclin B supplies a regulatory binding partner. Binding and phosphorylation regulate catalytic competence, so detecting CDK1 protein alone does not establish activity. The distinction makes a durable catalytic component reusable as the cell cycle changes its regulatory inputs.^[ref]

The cell-cycle activation feedback uses CDK1 activity as both an output and a regulatory input: activity promotes Cdc25 activation and suppresses Wee1, reinforcing release from inhibitory phosphorylation. The already described cell-cycle hysteresis experiment tests how that output depends on history at matched cyclin B input; the histone H1 kinase assay below explains what its output measures. A binding diagram alone cannot establish hysteresis.

Myt1 is a protein kinase distinct from Wee1. The cloned Xenopus laevis Myt1 phosphorylated Cdc2 at both inhibitory sites Thr14 and Tyr15; depletion experiments implicated it as the predominant Thr14-directed activity in Xenopus laevis egg extracts.^[ref]

Frog oocytes and egg extracts turned cell-cycle regulation into a transferable biochemical activity that could be purified, removed, restored and followed through time. Xenopus laevis provides large oocytes and abundant eggs containing stockpiled proteins and maternal messenger RNA. Early embryonic cycles can alternate rapidly between DNA replication and mitosis with little or no intervening growth phases. This makes extracts powerful for reconstructing the core oscillator, while also limiting direct extrapolation to the checkpoints and growth control of a differentiated somatic cell.

An immature oocyte is arrested in meiotic prophase. Hormonal stimulation can induce germinal-vesicle breakdown and progression towards a mature egg. Cytoplasm from a mature donor can induce maturation after injection into an immature recipient, establishing that a cytoplasmic activity can drive nuclear events. The activity was termed maturation-promoting factor, later also called M-phase-promoting factor. The foundational transfer experiments were performed in another frog species, Rana pipiens, so they should not be misattributed specifically to Xenopus.^[ref] Xenopus subsequently made the activity accessible to extensive extract assays and biochemical purification. Serial transfer also suggested amplification, rather than transfer of a fixed stoichiometric amount of a structural nuclear component.

Crushing unfertilized Xenopus eggs yields cytoplasm in which added nuclei can undergo characteristic mitotic events. Assay-guided fractionation of this material purified an activity capable of promoting early mitotic changes, making a connection between a cytoplasmic functional assay and specific protein components.^[ref] MPF is the complex of CDK1, historically Cdc2, with a mitotic cyclin such as cyclin B. The cyclin is a regulatory partner; CDK1 is the catalytic kinase. Nuclear-envelope breakdown, chromosome condensation and histone H1 kinase assays give complementary outputs. Co-purification with kinase activity is stronger when supported by immunodepletion and restoration of the active complex, because crude H1 phosphorylation is not uniquely specific to CDK1.

Cyclin synthesis and destruction provide the changing input. Cycling extracts show cyclin accumulation followed by destruction around mitotic exit. Blocking protein synthesis prevents repeated cycles; supplying appropriate cyclin material can restore mitotic entry, while a nondegradable cyclin prevents normal exit. These interventions distinguish association from a causal requirement for periodic synthesis and destruction.^[ref] Cyclin destruction is mediated by the anaphase-promoting complex, an ubiquitin ligase, followed by proteasomal degradation. It is therefore regulated proteolysis, not dilution or loss of kinase protein, that helps reset the mitotic machinery. Destruction of additional substrates coordinates chromosome separation with exit.

The response is not determined by cyclin concentration alone. Inhibitory CDK1 phosphorylation by Wee1 opposes activation; Cdc25 removes inhibitory phosphates. Active CDK1 promotes Cdc25 and suppresses Wee1, creating positive feedback. Xenopus extract experiments approaching the same sustained cyclin dose from an initially low or high kinase state found different maintained outputs, providing evidence of cell-cycle hysteresis experiment.^[ref] Monitoring endogenous cyclin destruction and the persistence of the added nondegradable input controls the possibility that the two histories merely leave different amounts of cyclin. This explains how gradual accumulation can produce a decisive transition rather than requiring every molecule to respond linearly.

Unfertilized eggs also reveal regulated arrest. They remain in meiotic metaphase II through cytostatic factor activity, which restrains the machinery for cyclin destruction. A fertilization-associated calcium signal releases that arrest, permitting cyclin destruction and meiotic completion. Experimentally adding calcium to an appropriately arrested extract can mimic this switch; a sham addition and monitoring cyclin and nuclear responses separate a genuine cycle transition from nonspecific extract damage.

Egg extracts additionally allow replication licensing to be separated from subsequent initiation. Added sperm chromatin can assemble nuclei and replicate, while transfer between extracts and manipulation of kinase state test why DNA is copied once per cycle. Licensing is permitted in a low-CDK state, while initiation-associated high CDK activity helps prevent relicensing before mitotic exit. A completed round of DNA synthesis must be distinguished from repair synthesis or simple nucleotide incorporation by appropriate product and template controls. The central contribution of Xenopus is experimental causality: a conserved cyclin–kinase system, feedback-controlled transitions, regulated proteolysis and replication control can be dissected in a cell-free cytoplasm rather than inferred only from correlations in dividing cells.

Direction arises from switching between mutually incompatible states, with feedback providing memory and regulated destruction resetting the system. Different transitions use related logic, but a steep response, a bistable switch and an irreversible molecular event are not identical. The cell cycle also requires checkpoints and once-per-cycle licensing so that the ordered biochemical states produce a correct sequence of physical events.

At the G1/S transition, growth signals promote cyclin-dependent kinase activity and relieve RB-mediated restraint on E2F. E2F-dependent expression of additional cell-cycle components can reinforce the transition. More generally, activation of a kinase together with removal of its inhibitor creates positive feedback. In yeast, multisite phosphorylation of Sic1 permits recognition by the Cdc4 ubiquitin-ligase system and degradation of an inhibitor of S-phase kinase. This supplies a threshold that prevents weak or premature signals from launching the next programme.^[ref] The detailed regulators vary across organisms and biological cell types; the conserved point is a coordinated transition from an inhibited state to one that reinforces its own activation.

Mitotic entry gives an experimentally accessible example of bistability. cyclin B binding increases the available CDK1 complex, but Wee1-dependent inhibitory phosphorylation can keep it inactive. Cdc25 removes the inhibitory phosphate. Active CDK1 promotes Cdc25 activity and suppresses Wee1, giving a positive-feedback loop and a double-negative loop. Over a suitable input range, both a low-activity and a high-activity state can be stable. If cyclin input rises from interphase, activation occurs at a higher threshold than the input required to maintain a pre-existing mitotic state. These distinct thresholds constitute hysteresis and prevent small fluctuations from repeatedly reversing a committed transition.

In egg extracts, nondegradable cyclin could be supplied while CDK activity was approached from different initial states. The same cyclin input then supported different persistent activities depending on history, directly distinguishing hysteresis from a single steep but history-independent response.^[ref] These are extract measurements, not universal numerical thresholds for every intact biological cell. A useful conceptual representation iswhere $u$ represents effective activating input. hysteresis supplies memory within this interval; it does not mean that the switch can never be reset.

Reset is achieved by coupling activation to delayed negative feedback and proteolysis. Mitotic kinase activity helps prepare activation of the anaphase-promoting complex with Cdc20, while the spindle checkpoint prevents productive progression until attachment conditions are met. Once this restraint is satisfied, APC/C-dependent ubiquitination promotes destruction of securin and cyclin B. securin loss allows separase to cleave cohesin, making sister-chromatid separation possible. Experiments identifying cohesin cleavage connected regulated proteolysis to a physical transition that simple reversal of a phosphorylation state cannot undo.^[ref] Chromatids cannot be returned to a pre-anaphase chromosome merely by reducing separase activity.

cyclin B destruction lowers CDK1 activity, allowing phosphatases to reverse mitotic phosphorylation and promoting an interphase state. Activation of anaphase-promoting complex with Cdh1 at low kinase activity can help keep cyclins low, while high kinase activity opposes that state. Thus low-CDK and high-CDK programmes are mutually antagonistic. Cyclin synthesis eventually provides a new activating input. Early experiments in extracts showed the importance of cyclin synthesis and destruction, including failure of normal exit with nondegradable cyclin.^[ref] A bistable activation module combined with an appropriate delayed reset can generate an ordered oscillation; a bistable module held at constant input need not oscillate on its own.

replication licensing enforces another essential directionality. At low CDK activity, origin recognition complex with Cdc6 and Cdt1 loads MCM2-7 double hexamers, establishing competence to replicate. In S phase, activating kinases promote origin firing while high CDK activity and additional controls prevent renewed licensing. In animal biological cells, geminin inhibition of Cdt1 and regulated degradation help separate these states. Purified-protein reconstitution demonstrated loading of the replication-helicase precursor as a distinct biochemical event.^[ref] Separating licensing from firing allows many origins to be prepared but prevents fired regions from being copied repeatedly during the same cycle. Lowering mitotic kinase activity must eventually restore licensing competence for the next cycle, rather than permit uncontrolled rereplication during the current S phase.

Checkpoint pathways modify or hold these switches when DNA is unreplicated, damaged or chromosomes are improperly attached; they do not supply the entire oscillator. Energy-consuming phosphorylation cycles, ubiquitination, proteolysis and resynthesis make the system a driven process, while feedback stabilizes distinct states. Thresholds provide commitment, hysteresis provides memory, destruction and cleavage enforce selected transitions, and licensing/checkpoints couple those transitions to one correct round of replication and segregation.

Positive feedback closes a causal loop whose net effect reinforces an initiating change. A loop with two inhibitory links can therefore have positive feedback. In signal transduction, a product that increases the activity of the enzyme making it illustrates reinforcement; the consequences depend on the full mathematical model, not just the loop sign. See signaling feedback.

A biological example is cell-cycle activation feedback. Cyclin B binds Cdc2, whose activity promotes activation of Cdc25; Cdc25 removes inhibitory phosphorylation from Cdc2, permitting further activation. Cdc2 also inhibits Wee1, an enzyme that inhibits Cdc2 through phosphorylation. That second return contains two inhibitions and therefore also has positive feedback. These are regulatory paths, not a claim that every connection is a single direct molecular encounter. ^[ref]

Reinforcement can preserve a decision after its initiating stimulus weakens: returning from the high state may require a lower input than entering it. The cell-cycle hysteresis experiment below tests this history dependence at matched cyclin B concentrations. A steep response alone is insufficient evidence of bistability, and finite observation times can make slow relaxation look like memory. A proposed switch must specify its input, readout and observation interval.

Wee1 is a protein kinase that inhibits CDK1 by adding a phosphate group at an inhibitory site. Purified human Wee1 phosphorylated Cdc2 at Tyr15 in the reported in vitro assay, with no Thr14 modification detected. A catalytic-site mutation abolished both the measured protein kinase activity and the ability to inhibit division. This identifies a catalytic brake rather than merely a correlated protein amount.^[ref]

Do not attribute all inhibitory CDK1 phosphorylation to Wee1: the Xenopus laevis Myt1 experiment separately identified activity toward both Thr14 and Tyr15. Nor does every phosphorylation inhibit its target: activating Thr161 modification in the studied Xenopus laevis Cdc2 has the opposite role. In cell-cycle activation feedback, suppression of Wee1 removes a brake on CDK1, reinforcing the transition without implying that the total amount of either protein instantly disappears.